<?xml version='1.0' encoding='utf-8'?>
<document id="29246152"><sentence text="Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology."><entity charOffset="96-105" id="DDI-PubMed.29246152.s1.e0" text="estradiol" /></sentence><sentence text="Estrogen is a vital hormone that regulates many biological functions within the body"><entity charOffset="0-8" id="DDI-PubMed.29246152.s2.e0" text="Estrogen" /></sentence><sentence text=" These include roles in the development of the secondary sexual organs in both sexes, plus uterine angiogenesis and proliferation during the menstrual cycle and pregnancy in women" /><sentence text=" The varied biological roles of estrogens in human health also make them a therapeutic target for contraception, mitigation of the adverse effects of the menopause, and treatment of estrogen-responsive tumours"><entity charOffset="32-41" id="DDI-PubMed.29246152.s4.e0" text="estrogens" /><entity charOffset="182-190" id="DDI-PubMed.29246152.s4.e1" text="estrogen" /><pair ddi="false" e1="DDI-PubMed.29246152.s4.e0" e2="DDI-PubMed.29246152.s4.e0" /><pair ddi="true" e1="DDI-PubMed.29246152.s4.e0" e2="DDI-PubMed.29246152.s4.e1" /></sentence><sentence text=" In addition, endogenous (e" /><sentence text="g" /><sentence text=" genetic variation) and external (e" /><sentence text="g" /><sentence text=" exposure to estrogen-like chemicals) factors are known to impact estrogen biology"><entity charOffset="13-21" id="DDI-PubMed.29246152.s9.e0" text="estrogen" /><entity charOffset="66-74" id="DDI-PubMed.29246152.s9.e1" text="estrogen" /><pair ddi="false" e1="DDI-PubMed.29246152.s9.e0" e2="DDI-PubMed.29246152.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29246152.s9.e0" e2="DDI-PubMed.29246152.s9.e1" /></sentence><sentence text=" To understand how these multipleÂ factors interact to determine an individual's response to therapy is complex, and may be best approached through a systems approach" /><sentence text="" /><sentence text="We present a physiologically-based pharmacokinetic model (PBPK) of estradiol, and validate it against plasma kinetics in humans following intravenous and oral exposure"><entity charOffset="67-76" id="DDI-PubMed.29246152.s12.e0" text="estradiol" /></sentence><sentence text=" We extend this model by replacing the intrinsic clearance term with: a detailed kinetic model of estrogen metabolism in the liver; or, a genome-scale model of liver metabolism"><entity charOffset="98-106" id="DDI-PubMed.29246152.s13.e0" text="estrogen" /></sentence><sentence text=" Both models were validated by their ability to reproduce clinical data on estradiol exposure"><entity charOffset="75-84" id="DDI-PubMed.29246152.s14.e0" text="estradiol" /></sentence><sentence text=" We hypothesise that the enhanced mechanistic information contained within these models will lead to more robust predictions of the biological phenotype that emerges from the complex interactions between estrogens and the body"><entity charOffset="204-213" id="DDI-PubMed.29246152.s15.e0" text="estrogens" /></sentence><sentence text="" /><sentence text="To demonstrate the utility of these models we examine the known drug-drug interactions between phenytoin and oral estradiol"><entity charOffset="95-104" id="DDI-PubMed.29246152.s17.e0" text="phenytoin" /><entity charOffset="114-123" id="DDI-PubMed.29246152.s17.e1" text="estradiol" /><pair ddi="false" e1="DDI-PubMed.29246152.s17.e0" e2="DDI-PubMed.29246152.s17.e0" /><pair ddi="false" e1="DDI-PubMed.29246152.s17.e0" e2="DDI-PubMed.29246152.s17.e1" /></sentence><sentence text=" We are able to reproduce the approximate 50% reduction in area under the concentration-time curve for estradiol associated with this interaction"><entity charOffset="103-112" id="DDI-PubMed.29246152.s18.e0" text="estradiol" /></sentence><sentence text=" Importantly, the inclusion of a genome-scale metabolic model allows the prediction of this interaction without directly specifying it within the model" /><sentence text=" In addition, we predict that PXR activation by drugs results in an enhanced ability of the liver to excrete glucose"><entity charOffset="109-116" id="DDI-PubMed.29246152.s20.e0" text="glucose" /></sentence><sentence text=" This has important implications for the relationship between drug treatment and metabolic syndrome" /><sentence text="" /><sentence text="We demonstrate how the novel coupling of PBPK models with genome-scale metabolic networks has the potential to aid prediction of drug action, including both drug-drug interactions and changes to the metabolic landscape that may predispose an individual to disease development" /><sentence text="" /></document>